Brief: Amneal Receives FDA Approval for Propofol Injectable Emulsion Single Dose Vials
20/08/2024 13:27
Aug 20 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O :
* AMNEAL RECEIVES U.S. FDA APPROVAL FOR PROPOFOL INJECTABLE
EMULSION SINGLE DOSE VIALS
* AMNEAL PHARMACEUTICALS INC - EXPECTS TO LAUNCH PROPOFOL IN
Q4 OF
2024
Source text for Eikon: ID:nBw6Q4zWva
Further company coverage: AMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-3M Company, Constellation Energy, Metropolitan Bank Holding
US FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary